Cue Biopharma
Price & Volume
Stats
See more52W Range | $4.97-$45.50 |
Market Cap | $151.5M |
Shares Short | 792,553 |
Financials
See moreRevenue (12 Mos) | $37.6M |
Revenue Growth (YoY) | 166.7% |
Gross Profit (12 Mos) | -$37.3M |
Diluted EPS | -$29.59 |
News
See moreYahoo Finance • last month
Premarket movers: crypto, AI stocks rise, Greenland plays soar
Yahoo Finance • last month
Cue Biopharma Shares Jump 41.6% Premarket Following Phase 2 Trial Results
Yahoo Finance • 4 months ago
Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
Yahoo Finance • 4 months ago
Cue Biopharma to raise $50M in oversubscribed private placement
About
CEO | Dr. Shao-Lee Lin M.D., Ph.D. |
Address | 40 Guest Street, Boston, MA, United States, 02135 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 29 |